ArticleBMC cancer2026

ITGAX is associated with poor prognosis and an immune-inflammatory microenvironment in clear cell renal cell carcinoma.

Xuehua Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.